Cision PR Newswire

Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with...

- ASC30 reduced HbA1c by a placebo-adjusted 1.7%, 1.6% and 1.7% from baseline for 40 mg, 60 mg and 80 mg, respectively, at 12 weeks, the...

Huawei Unveils Xinghe AI Campus Full-Scope Security Solution, Pioneering a New Paradigm for Campus Protection in the AI Era

SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- During HUAWEI CONNECT 2025, Huawei unveiled its Xinghe AI Campus Full-Scope Security Solution—an innovative offering that harnesses AI...

WiMi Has Developed a Scalable Quantum Neural Network (SQNN) Technology Based on Multi-quantum-device Collaborative Computing

BEIJING, Sept. 19, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider,...

Huawei Charts the Future of Smart Technology with Pioneering Product Lineup

PARIS, Sept. 19, 2025 /PRNewswire/ -- Today, under the banner of "Ride the Wind," Huawei hosted its Global Innovative Product Launch event in Paris....

CATL and Springer Nature launch journal Watt to connect science and industry

HONG KONG, Sept. 19, 2025 /PRNewswire/ -- 21C Lab, the cutting-edge innovation arm of CATL dedicated to next-generation battery technologies, and Springer Nature, a world-leading...